Aptevo Therapeutics Inc [NASDAQ: APVO] gained 81.91% or 2.31 points to close at $5.13 with a heavy trading volume of 124153133 shares.
It opened the trading session at $6.17, the shares rose to $13.1099 and dropped to $4.8, the range by which the price of stock traded the whole day. The daily chart for APVO points out that the company has recorded -93.73% loss over the past six months.
If we look at the average trading volume of 279.57K shares, APVO reached to a volume of 124153133 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Aptevo Therapeutics Inc [APVO]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for APVO shares is $420.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on APVO stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Ladenburg Thalmann have made an estimate for Aptevo Therapeutics Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on November 05, 2018. While these analysts kept the previous recommendation, Piper Jaffray raised their target price to Overweight. The new note on the price target was released on October 05, 2017, representing the official price target for Aptevo Therapeutics Inc stock.
Trading performance analysis for APVO stock
Aptevo Therapeutics Inc [APVO] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 10.32. With this latest performance, APVO shares dropped by -17.26% in over the last four-week period, additionally sinking by -93.73% over the last 6 months – not to mention a drop of -99.10% in the past year of trading.
Aptevo Therapeutics Inc [APVO]: A deeper dive into fundamental analysis
Return on Equity for this stock declined to -182.54%, with Return on Assets sitting at -182.54%.
An analysis of Institutional ownership at Aptevo Therapeutics Inc [APVO]
There are presently around $3.31%, or 3.41%% of APVO stock, in the hands of institutional investors.
